Author

Thomas Seufferlein

Hot topics in HPB medical oncology
Hot topics in HPB medical oncology

Thomas Seufferlein

NGS-guided therapies in GI oncology
NGS-guided therapies in GI oncology

Thomas Seufferlein

Colon cancer with synchronous not (yet) resectable liver metastases: A real life MDT session
Colon cancer with synchronous not (yet) resectable liver metastases: A real life MDT session

Thomas Seufferlein

Neoadjuvant therapy for resectable tumours
Neoadjuvant therapy for resectable tumours

Thomas Seufferlein

Follow-up presentation
Follow-up presentation

Thomas Seufferlein

ASSESSMENT OF LIVER FIBROSIS BY ACOUSTIC RADIATION FORCE IMPULSE IMAGING COMBINED WITH RESULTS OF MINI-LAPAROSCOPY AND HISTOLOGY EVALUATION: A SINGLE-CENTER TRIAL
ASSESSMENT OF LIVER FIBROSIS BY ACOUSTIC RADIATION FORCE IMPULSE IMAGING COMBINED WITH RESULTS OF MINI-LAPAROSCOPY AND HISTOLOGY EVALUATION: A SINGLE-CENTER TRIAL

Thomas Seufferlein  et al.

Q&A Acute presentation of T4 colon cancer
Q&A Acute presentation of T4 colon cancer

Thomas Seufferlein  et al.

Summary: Advanced colorectal cancer
Summary: Advanced colorectal cancer

Thomas Seufferlein  et al.

THERAPEUTIC POTENTIAL OF TNK1 IN PREVENTION AND HEALING OF INTESTINAL BARRIER BREACH
THERAPEUTIC POTENTIAL OF TNK1 IN PREVENTION AND HEALING OF INTESTINAL BARRIER BREACH

Thomas Seufferlein  et al.

Metastasised colorectal cancer (Complete Session)
Metastasised colorectal cancer (Complete Session)

Thomas Seufferlein  et al.

PEMBROLIZUMAB-INDUCED EXACERBATION OF HEPATITIS D
PEMBROLIZUMAB-INDUCED EXACERBATION OF HEPATITIS D

Thomas Seufferlein  et al.

PPDPF IMPACTS PANCREATIC DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELL DERIVED PANCREATIC PROGENITORS
PPDPF IMPACTS PANCREATIC DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELL DERIVED PANCREATIC PROGENITORS

Thomas Seufferlein  et al.

INTESTINE-SPECIFIC DELETION OF TNK1 KINASE AMELIORATES COLITIS BY MODULATING MICROBIOTA COMPOSITION
INTESTINE-SPECIFIC DELETION OF TNK1 KINASE AMELIORATES COLITIS BY MODULATING MICROBIOTA COMPOSITION

Thomas Seufferlein  et al.

ALLELIC REGULATION OF CK19 DURING MATURATION OF PANCREATIC DUCTAL CELLS
ALLELIC REGULATION OF CK19 DURING MATURATION OF PANCREATIC DUCTAL CELLS

Thomas Seufferlein  et al.

IS ATM DEFICIENCY PROVIDE A BENEFIT TO PANCREATIC TUMOR CELLS IN A METABOLIC STRESS CONTEXT?
IS ATM DEFICIENCY PROVIDE A BENEFIT TO PANCREATIC TUMOR CELLS IN A METABOLIC STRESS CONTEXT?

Thomas Seufferlein  et al.

LONG TERM RESPONSE TO RITUXIMAB IN PATIENTS WITH TYPE 1 AUTOIMMUNE PANCREATITIS
LONG TERM RESPONSE TO RITUXIMAB IN PATIENTS WITH TYPE 1 AUTOIMMUNE PANCREATITIS

Thomas Seufferlein  et al.

MODELLING PANCREATIC FACETS OF JOHANSON-BLIZZARD SYNDROME IN A DISH
MODELLING PANCREATIC FACETS OF JOHANSON-BLIZZARD SYNDROME IN A DISH

Thomas Seufferlein  et al.

RINT1 DOWNREGULATION DISRUPTS PANCREATIC DUCTAL ADENOCARCINOMA HOMEOSTASIS
RINT1 DOWNREGULATION DISRUPTS PANCREATIC DUCTAL ADENOCARCINOMA HOMEOSTASIS

Thomas Seufferlein  et al.

ATM DEFICIENCY DRIVES METABOLIC REPROGRAMMING IN PANCREATIC CANCER CELLS
ATM DEFICIENCY DRIVES METABOLIC REPROGRAMMING IN PANCREATIC CANCER CELLS

Thomas Seufferlein  et al.

PRECLINICAL VALIDATION OF NOVEL GENOTYPE-SPECIFIC THERAPEUTIC CONCEPTS FOR ATM-DEFICIENT PANCREATIC CANCER
PRECLINICAL VALIDATION OF NOVEL GENOTYPE-SPECIFIC THERAPEUTIC CONCEPTS FOR ATM-DEFICIENT PANCREATIC CANCER

Thomas Seufferlein  et al.

Item 1 - 20 / 47
1
2 3